COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • °øÁö»çÇ×

°øÁö»çÇ×

¾Æ¹Ù¹ÙÀÌ¿À°¡ ¼Ò½ÄÀ» ÀüÇÕ´Ï´Ù.
Á¦¸ñ Precision Antibody ÀÇ Korea ´ë¸®Á¡ ÀÔ´Ï´Ù. (Korea Distributor)
ÀÛ¼ºÀÚ abbabio
ÀÛ¼ºÀÏÀÚ 2018-11-30
Á¶È¸¼ö 352
 
Precision Antibody a wholly owned service division of A&G Pharmaceutical, Inc.  has become recognized as a preeminent contract antibody development company. On average, Precision Antibody can complete a project four to five times faster than our competition, with a success rate exceeding 90%. Since our establishment in 2000, Precision Antibody has developed more than 1,000 novel, customized antibodies for pharmaceutical and biotechnology companies as well as federal and academic research laboratories.
Precision Antibody� services are distinguished by:
  • Consistently rapid turnaround on projects that yield successful custom development of high-affinity, high-content, application-specific antibodies
  • Ability to deliver on challenging projects, such as antibodies that recognize a single amino acid mutation, cleavage site-specific antibodies, or antibodies with a Kd as low as 1 x 10-12 M
  • No-risk guarantee whereby Precision Antibody� assumes the majority of the financial risk until successful antibodies are delivered to the client.
 
www.precisionantibody.com
 
 
÷ºÎÆÄÀÏ